Bhatnagar Anish
CHIEF EXECUTIVE OFFICER · SOLENO THERAPEUTICS INC
- 2024
- May 18, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Bhatnagar Anish files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Meredith Manning - $229K in SLNO purchases and sales in the last 12 months
- Michael F. Huang - $200K in SLNO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Bhatnagar Anish?
Bhatnagar Anish is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER of SOLENO THERAPEUTICS INC (SLNO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Bhatnagar Anish last file a Form 4?
The most recent primary Form 4 on record is dated 18 May 2026, one of 3 filings going back to 2024.
Has Bhatnagar Anish been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.07M) across all tracked filings.
